4-Methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 335-342

  Saito, Teruyoshi ^a   Tamura, Dai ^a   Nakamura, Tatsuro ^a   Makita, Yukihisa ^a   Ariyama, Hitomi ^a   Komiyama, Keiji ^a   Oshihara, Tomoko ^a   Asano, Ryuji ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

4 Methylumbelliferone; Apoptosis; Canine mammary tumor; Hyaluronan; Hyaluronan synthase

Indexed keywords

HYALURONAN SYNTHASE; HYALURONIC ACID; HYMECROMONE; MESSENGER RNA; PROTEIN BAX; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BAX GENE; BIOSYNTHESIS; BREAST TUMOR; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HAS2 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; DOGS; FEMALE; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; HYMECROMONE; INDICATORS AND REAGENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 84872864145     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2100     Document Type: Article

References (46)

1. Priester WA and Mantel N: Occurrence of tumors in domestic animals. Data from 12 United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst 47: 1333-1344, 1971.
2. Sorenmo K: Canine mammary gland tumors. Vet Clin North Am Small Anim Pract 33: 573-596, 2003.
3. Graham JC and Myers RK: The prognostic significance of angiogenesis in canine mammary tumors. J Vet Intern Med 13: 416-418, 1999.
4. Nieto A, Pena L, Perez-Alenza MD, Sanchez MA, Flores JM and Castano M: Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 37: 239-247, 2000.
5. Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, Castle J, Palombo F, Viti V, Mesiti G, Zappulli V, Marconato L, Abramo F, Ciliberto G, Lahm A, La Monica N and de Rinaldis E: Comparative expression pathways analysis of human and canine mammary tumors. BMC Genomics 10: 135, 2009.
6. Standberg JD and Goodman DG: Animal model of human disease: canine mammary neoplasia. Am J Pathol 75: 225-228, 1974.
7. Pinho SS, Carvalho S, Cabral J, Reis CA and Gartner F: Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res 159: 165-172, 2012.
8. Weismann B, Rapport MM, Linker A and Meyer K: Isolation of the aldobionic acid of umbilical cord hyaluronic acid. J Biol Chem 205: 205-211, 1953.
9. Toole BP: Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4: 528-539, 2004.
10. Turley EA, Noble PW and Bourguignon LY: Signaling properties of hyaluronan receptors. J Biol Chem 277: 4589-4592, 2002.
11. Fraser JR, Laurent TC and Laurent UB: Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242: 27-33, 1997.
12. Menzel E and Farr C: Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 131: 3-11, 1998.
13. Auvinen P, Tammi RH, Parkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M and Kosma VM: Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156: 529-536, 2000.
14. Anttila MA, Tammi RH, Tammi MI, Syrjanen KJ, Saarikoski SV and Kosma VM: High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 60: 150-155, 2000.
15. Lipponen P, Aaltomaa S, Tammi R, Tammi M, Agren U and Kosma VM: High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer 37: 849-856, 2001.
16. Golshani R, Lopez L, Estrella V, Kramer M, Iida N and Lokeshwar VB: Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res 68: 483-491, 2008.
17. Udabage L, Brownlee GR, Waltham M, Blick T, Walker EC, Heldin P, Nilsson SK, Thompson EW and Brown TJ: Antisense-mediated suppression of hyaluronan synthase-2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res 65: 6139-6150, 2005.
18. Liu N, Gao F, Han Z, Xu X, Underhill CB and Zhang L: Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 61: 5207-5214, 2001.
19. Cichy J and Pure E: The liberation of CD44. J Cell Biol 161: 839-843, 2003.
20. Cheung WF, Cruz TF and Turley EA: Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem Soc Trans 27: 135-142, 1999.
21. Itano N, Zhuo L and Kimata K: Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci 99: 1720-1725, 2008.
22. Gotte M and Yip GW: Heparanase, Hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66: 10233-10237, 2006.
23. Serra M, Rabanal RM, Miquel L, Domenzain C and Bassols A: Differential expression of CD44 in canine melanocytic tumours. J Comp Path 130: 171-180, 2004.
24. Paltian V, Alldinger S, Baumgartner W and Wohlsein P: Expression of CD44 in canine mammary tumours. J Comp Path 141: 237-247, 2009.
25. Nakamura T, Funahashi M, Takagaki K, Munakata H, Tanaka K, Saito Y and Endo M: Effect of 4-methylumbelliferone on cell-free synthesis of hyaluronic acid. Biochem Mol Biol Int 43: 263-268, 1997.
26. Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, Ito M, Maruo Y, Sato H, Yasuda T, Mita S, Kimata K and Itano N: A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-Methylumbelliferone. J Biol Chem 279: 33281-33289, 2004.
27. Kultti A, Pasonen-Seppanen S, Jauhiainen M, Rilla KJ, Karna R, Pyoria E, Tammi RH and Tammi MI: 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 315: 1914-1923, 2009.
28. Lokeshwar VB, Lopez LE, Munoz D, Chi A, Shirodkar SP, Lokeshwar SD, Escudero DO, Dhir N and Altman N: Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res 70: 2613-2623, 2010.
29. Yoshihara S, Kon A, Kudo D, Nakazawa H, Kakizaki I, Sasaki M, Endo M and Takagaki K: A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells. FEBS Lett 579: 2722-2726, 2005.
30. Knudson W and Knudson CB: Assembly of a chondrocyte-like pericellular matrix on non-chondrogenic cells. Role of the cell surface hyaluronan receptors in the assembly of a pericellular matrix. J Cell Sci 99: 227-235, 1991.
31. Hansen MB, Nielsen SE and Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210, 1989.
32. Twentyman PR and Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56: 279-285, 1987.
33. Saito T, Kawana H, Azuma K, Toyoda A, Fujita H, Kitagawa M and Harigaya K: Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane. Int J Oncol 39: 1311-1320, 2011.
34. Simpson M, Reiland J, Burger S, Furcht L, Spicer A, Oegema T and MaCarthy JB: Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J Biol Chem 276: 17949-17957, 2001.
35. Li Y, Li L, Brown TJ and Heldin P: Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 120: 2557-2567, 2007.
36. Xia W, Spector S, Hardy L, Zhao S, Saluk A, Alemane L and Spector NL: Tumor selective G2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine. Proc Natl Acad Sci USA 97: 7494-7499, 2000.
37. Arai E, Nishida Y, Wasa J, Urakawa H, Zhuo L, Kimata K, Kozawa E, Futamura N and Ishiguro N: Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo. Br J Cancer 105: 1839-1849, 2011.
38. Urakawa H, Nishida Y, Wasa J, Arai E, Zhuo L, Kimata K, Kozawa E, Futamura N and Ishiguro N: Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. Int J Cancer 130: 454-466, 2012.
39. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Agustine ML, Calabro A Jr., Kubalak S, Klewer SE and McDonald JA: Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106: 349-360, 2000.
40. Vigetti D, Genasetti A, Karousou E, Viola M, Moretto P, Clerici M, Deleonibus S, De Luca G, Hascall VC and Passi A: Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-kappaB (NF-kappaB) pathway. J Biol Chem 285: 24639-24645, 2010.
41. Itano N and Kimata K: Mammalian hyaluronan synthases. IUBMB Life 54: 195-199, 2002.
42. Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S, Xing F, Liu W, Pandey PR, Fukuda K, Modur V, Ghosh A, Wilber A and Watabe K: Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res 72: 537-547, 2012.
43. Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M and Kosma VM: Hyaluronan in human malignancies. Exp Cell Res 317: 383-391, 2011.
44. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L and Hung MC: Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 272: 27913-27918, 1997.
45. Ouhit A, Abd Elmageed ZY, Abdraboh ME, Lioe TF and Raj MH: In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol 171: 2033-2039, 2007.
46. Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, Matsuda S, Kimata K, Iwata H and Hamaguchi M: Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol Biol Cell 12: 1859-1868, 2001.